Atlas Trials

Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm

Clinical trial NCT05738629 · UNKNOWN

Trial details

NCT number
NCT05738629
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Dry Eye Disease
Start date
2023-03-01
Primary completion
2025-02-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.